Long-Term Results of the RAPCO Trials

BACKGROUND:An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial a...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 142; no. 14; pp. 1330 - 1338
Main Authors Buxton, Brian F, Hayward, Philip A, Raman, Jai, Moten, Simon C, Rosalion, Alexander, Gordon, Ian, Seevanayagam, Siven, Matalanis, George, Benedetto, Umberto, Gaudino, Mario, Hare, David L
Format Journal Article
LanguageEnglish
Published United States by the American College of Cardiology Foundation and the American Heart Association, Inc 06.10.2020
Subjects
Adult
Aged
Coronary Artery Bypass
Disease-Free Survival
Female
Humans
Male
Mammary Arteries
Middle Aged
Mortality
Radial Artery
Survival Rate
Vascular Patency
coronary artery bypass
saphenous vein
radial artery
Online AccessGet full text

Cover

Abstract BACKGROUND:An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). METHODS:In RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. RESULTS:In the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23–0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30–0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15–1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47–1.22]). CONCLUSIONS:The 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. REGISTRATION:URLhttps://www.clinicaltrials.gov; Unique identifierNCT00475488.
AbstractList An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). In RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. In the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23-0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30-0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15-1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47-1.22]). The 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00475488.
Background: An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). Methods: In RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. Results: In the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23–0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30–0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15–1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47–1.22]). Conclusions: The 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT00475488.
BACKGROUNDAn internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). METHODSIn RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. RESULTSIn the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23-0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30-0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15-1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47-1.22]). CONCLUSIONSThe 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT00475488.
BACKGROUND:An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second conduit. The RAPCO trials (Radial Artery Patency and Clinical Outcomes) were designed to compare the long-term patency of the radial artery (RA) with that of the right internal thoracic artery (RITA) and the saphenous vein (SV). METHODS:In RAPCO-RITA (the RITA versus RA arm of the RAPCO trial), 394 patients <70 years of age (or <60 years of age if they had diabetes mellitus) were randomized to receive RA or free RITA graft on the second most important coronary target. In RAPCO-SV (the SV versus RA arm of the RAPCO trial), 225 patients ≥70 years of age (or ≥60 years of age if they had diabetes mellitus) were randomized to receive RA or SV graft. The primary outcome was 10-year graft failure. Long-term mortality was a nonpowered coprimary end point. The main analysis was by intention to treat. RESULTS:In the RA versus RITA comparison, the estimated 10-year patency was 89% for RA versus 80% for free RITA (hazard ratio for graft failure, 0.45 [95% CI, 0.23–0.88]). Ten-year patient survival estimate was 90.9% in the RA arm versus 83.7% in the RITA arm (hazard ratio for mortality, 0.53 [95% CI, 0.30–0.95]). In the RA versus SV comparison, the estimated 10-year patency was 85% for the RA versus 71% for the SV (hazard ratio for graft failure, 0.40 [95% CI, 0.15–1.00]), and 10-year patient survival estimate was 72.6% for the RA group versus 65.2% for the SV group (hazard ratio for mortality, 0.76 [95% CI, 0.47–1.22]). CONCLUSIONS:The 10-year patency rate of the RA is significantly higher than that of the free RITA and better than that of the SV. REGISTRATION:URLhttps://www.clinicaltrials.gov; Unique identifierNCT00475488.
Author Hayward, Philip A
Gordon, Ian
Benedetto, Umberto
Hare, David L
Raman, Jai
Matalanis, George
Moten, Simon C
Seevanayagam, Siven
Buxton, Brian F
Rosalion, Alexander
Gaudino, Mario
AuthorAffiliation Department of Cardiac Surgery, Austin Hospital, Melbourne, Australia (B.F.B., J.R., S.C.M., S.S., G.M.). Faculty of Medicine, Dentistry and Health Sciences (B.F.B., P.A.H., J.R., A.R., S.S., G.M., D.L.H.), University of Melbourne, Australia. Statistical Consulting Centre (I.G.), University of Melbourne, Australia. Bristol Heart Institute, University of Bristol, United Kingdom (U.B.). Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY (M.G.). Department of Cardiology, Austin Health, Melbourne, Australia (D.L.H.)
AuthorAffiliation_xml – name: Department of Cardiac Surgery, Austin Hospital, Melbourne, Australia (B.F.B., J.R., S.C.M., S.S., G.M.). Faculty of Medicine, Dentistry and Health Sciences (B.F.B., P.A.H., J.R., A.R., S.S., G.M., D.L.H.), University of Melbourne, Australia. Statistical Consulting Centre (I.G.), University of Melbourne, Australia. Bristol Heart Institute, University of Bristol, United Kingdom (U.B.). Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY (M.G.). Department of Cardiology, Austin Health, Melbourne, Australia (D.L.H.)
Author_xml – sequence: 1
  givenname: Brian
  surname: Buxton
  middlename: F
  fullname: Buxton, Brian F
  organization: Department of Cardiac Surgery, Austin Hospital, Melbourne, Australia (B.F.B., J.R., S.C.M., S.S., G.M.). Faculty of Medicine, Dentistry and Health Sciences (B.F.B., P.A.H., J.R., A.R., S.S., G.M., D.L.H.), University of Melbourne, Australia. Statistical Consulting Centre (I.G.), University of Melbourne, Australia. Bristol Heart Institute, University of Bristol, United Kingdom (U.B.). Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY (M.G.). Department of Cardiology, Austin Health, Melbourne, Australia (D.L.H.)
– sequence: 2
  givenname: Philip
  surname: Hayward
  middlename: A
  fullname: Hayward, Philip A
– sequence: 3
  givenname: Jai
  surname: Raman
  fullname: Raman, Jai
– sequence: 4
  givenname: Simon
  surname: Moten
  middlename: C
  fullname: Moten, Simon C
– sequence: 5
  givenname: Alexander
  surname: Rosalion
  fullname: Rosalion, Alexander
– sequence: 6
  givenname: Ian
  surname: Gordon
  fullname: Gordon, Ian
– sequence: 7
  givenname: Siven
  surname: Seevanayagam
  fullname: Seevanayagam, Siven
– sequence: 8
  givenname: George
  surname: Matalanis
  fullname: Matalanis, George
– sequence: 9
  givenname: Umberto
  surname: Benedetto
  fullname: Benedetto, Umberto
– sequence: 10
  givenname: Mario
  surname: Gaudino
  fullname: Gaudino, Mario
– sequence: 11
  givenname: David
  surname: Hare
  middlename: L
  fullname: Hare, David L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33017209$$D View this record in MEDLINE/PubMed
BookMark eNpVkNtKw0AQhhdRbD28gsQLwZvU2VO2exmCh0KxUur1stlObDVtdDeh-PZuSRW8GubnmxnmOyPH22aLhFxTGFGa0btiMi9ep_liMnvOn_KY6REIKZg6IkMqmUiF5PqYDAFAp4ozNiBnIbzHNuNKnpIB50AVAz0kN9Nm-5Yu0G-SOYaubkPSVEm7wmSevxSzZOHXtg4X5KSKBS8P9Zy8Ptwviqd0OnucFPk0dUJpmTIJTmUloHAl8syKylpunVZaZXYpmROldgC0tM7GP0COZQaCQal0iejG_Jzc9ns_ffPVYWjNZh0c1rXdYtMFw4QYj4WiwCKqe9T5JgSPlfn0643134aC2Vsy_y3FTJveUpy9Opzpyg0u_yZ_tURA9MCuqVv04aPudujNCm3drkz0CHsyZcCARqmQ7iPJfwDY-HM0
CitedBy_id crossref_primary_10_1007_s00595_023_02679_9
crossref_primary_10_1053_j_semtcvs_2021_03_014
crossref_primary_10_1161_CIRCULATIONAHA_120_052522
crossref_primary_10_1016_j_carrev_2021_01_014
crossref_primary_10_24884_0042_4625_2023_182_1_11_19
crossref_primary_10_1097_HCO_0000000000001162
crossref_primary_10_1016_j_xjtc_2020_10_030
crossref_primary_10_1016_j_amjcard_2023_12_047
crossref_primary_10_1093_eurheartj_ehab096
crossref_primary_10_1016_j_ahj_2024_01_006
crossref_primary_10_1097_HCO_0000000000000875
crossref_primary_10_1097_HCO_0000000000000994
crossref_primary_10_1097_HCO_0000000000000908
crossref_primary_10_17116_Cardiobulletin2021160415
crossref_primary_10_1161_JAHA_120_019206
crossref_primary_10_1016_j_athoracsur_2023_06_010
crossref_primary_10_1055_s_0042_1745805
crossref_primary_10_1007_s12055_020_01111_y
crossref_primary_10_1016_j_tcm_2022_12_002
crossref_primary_10_1177_10892532221101298
crossref_primary_10_1016_j_surg_2024_04_011
crossref_primary_10_1093_ejcts_ezad021
crossref_primary_10_1161_CIRCULATIONAHA_122_061766
crossref_primary_10_1016_j_jss_2024_06_013
crossref_primary_10_1016_j_xjtc_2021_09_039
crossref_primary_10_1093_eurheartj_ehad108
crossref_primary_10_1016_j_athoracsur_2021_09_015
crossref_primary_10_5761_atcs_oa_23_00084
crossref_primary_10_1016_j_hlc_2024_01_035
crossref_primary_10_1016_j_jcin_2022_11_035
crossref_primary_10_1093_ejcts_ezae106
crossref_primary_10_1161_CIRCULATIONAHA_122_063795
crossref_primary_10_1016_j_jtcvs_2021_01_015
crossref_primary_10_1253_circj_CJ_20_1282
crossref_primary_10_1016_j_tcm_2021_09_007
crossref_primary_10_1016_j_mayocp_2022_10_003
crossref_primary_10_1093_ejcts_ezae188
crossref_primary_10_1016_j_athoracsur_2022_11_041
crossref_primary_10_3390_jcm13030761
crossref_primary_10_1016_j_ijcard_2022_10_156
crossref_primary_10_1016_j_xjtc_2021_10_012
crossref_primary_10_3389_fcvm_2023_1125126
crossref_primary_10_1097_HCO_0000000000001066
crossref_primary_10_1016_j_jtcvs_2021_06_062
crossref_primary_10_1161_CIRCULATIONAHA_120_049299
crossref_primary_10_1055_s_0041_1729762
crossref_primary_10_1111_jocs_17195
crossref_primary_10_1007_s11886_022_01746_w
crossref_primary_10_1016_j_xjon_2020_11_009
crossref_primary_10_1016_j_athoracsur_2020_05_118
crossref_primary_10_5761_atcs_oa_24_00029
crossref_primary_10_1093_ejcts_ezac475
crossref_primary_10_3349_ymj_2022_0586
crossref_primary_10_1093_ejcts_ezac435
crossref_primary_10_1093_ejcts_ezac436
crossref_primary_10_1016_j_jtcvs_2022_03_010
crossref_primary_10_1161_CIRCULATIONAHA_121_053194
crossref_primary_10_1093_ejcts_ezad163
crossref_primary_10_3390_jcm12072594
crossref_primary_10_1016_j_jtcvs_2021_08_041
crossref_primary_10_1016_j_carrev_2021_10_007
crossref_primary_10_1016_j_jtcvs_2023_06_017
crossref_primary_10_1016_j_athoracsur_2021_09_076
crossref_primary_10_1016_j_jacasi_2021_11_009
crossref_primary_10_1016_j_jtcvs_2021_03_105
crossref_primary_10_3390_ijms24043306
crossref_primary_10_1053_j_optechstcvs_2021_09_001
crossref_primary_10_1093_ejcts_ezac345
crossref_primary_10_1093_icvts_ivab279
crossref_primary_10_1177_02184923231170062
crossref_primary_10_1016_j_jtcvs_2021_07_047
crossref_primary_10_1097_CRD_0000000000000744
crossref_primary_10_3390_jcm12072516
crossref_primary_10_23736_S0021_9509_21_11826_9
crossref_primary_10_1007_s12055_020_01105_w
crossref_primary_10_1053_j_optechstcvs_2021_01_001
Cites_doi 10.1016/j.hlc.2011.01.001
10.1056/NEJMoa1716026
10.1016/j.jtcvs.2008.10.029
10.1016/j.jtcvs.2016.05.022
10.1016/S0140-6736(19)31997-X
10.1016/j.athoracsur.2012.12.038
10.1161/CIR.0000000000000095
10.1080/01621459.1999.10474144
10.1001/jamasurg.2013.3721
10.1093/icvts/ivz129
10.1093/ejcts/ezv467
10.1016/j.athoracsur.2017.10.058
10.1016/j.jtcvs.2012.01.052
10.1016/S0022-5223(19)36947-8
10.1093/ejcts/ezv093
10.1016/j.jtcvs.2011.10.029
10.1161/JAHA.117.008010
10.1016/s0003-4975(03)01018-x
10.1161/CIRCULATIONAHA.104.512905
10.1093/ejcts/ezu111
10.1161/CIRCULATIONAHA.111.030536
10.1056/NEJMoa1808783
10.1053/j.semtcvs.2017.05.018
ContentType Journal Article
Contributor Doolan, Laurie
Rowe, Michael
Lim, Ruth
O'Donnell, David
McNicol, Larry
Eng, John
Brennan, John
Fernando, Dharsh
Smith, Gerard
Jackson, Anthony
Nadurata, Voltaire
Horrigan, Mark
Ecclestone, David
Mehta, Nilesh
Proimos, George
Sylviris, Stephen
Wellman, Chris
Nadarajah, Nim
Calafiore, Paul
Gaer, Jullien
Chan, Robert
Sia, Ben
Jones, Elizabeth
Fabini, Robert
Cotroneo, John
Komeda, Masashi
Tonkin, Anew
Molan, Maurice
Dortimer, Anthony
Webb, Christopher
Shaw, Margaret
Johns, Jennifer
Gerbo, Sana
Clark, David
Hameed, Irbaz
Barlis, Peter
Anaveker, Nagesh
Farouque, Omar
Kearney, Leighton
Negri, Justin
Bellomo, Rinaldo
Oliver, Leslie
Kertes, Paul
Chan, Boniface
Dick, Ronald
Contributor_xml – sequence: 1
  givenname: Jullien
  surname: Gaer
  fullname: Gaer, Jullien
– sequence: 2
  givenname: Justin
  surname: Negri
  fullname: Negri, Justin
– sequence: 3
  givenname: Masashi
  surname: Komeda
  fullname: Komeda, Masashi
– sequence: 4
  givenname: Rinaldo
  surname: Bellomo
  fullname: Bellomo, Rinaldo
– sequence: 5
  givenname: Laurie
  surname: Doolan
  fullname: Doolan, Laurie
– sequence: 6
  givenname: Larry
  surname: McNicol
  fullname: McNicol, Larry
– sequence: 7
  givenname: John
  surname: Brennan
  fullname: Brennan, John
– sequence: 8
  givenname: Robert
  surname: Chan
  fullname: Chan, Robert
– sequence: 9
  givenname: David
  surname: Clark
  fullname: Clark, David
– sequence: 10
  givenname: Ronald
  surname: Dick
  fullname: Dick, Ronald
– sequence: 11
  givenname: Anthony
  surname: Dortimer
  fullname: Dortimer, Anthony
– sequence: 12
  givenname: David
  surname: Ecclestone
  fullname: Ecclestone, David
– sequence: 13
  givenname: Omar
  surname: Farouque
  fullname: Farouque, Omar
– sequence: 14
  givenname: Dharsh
  surname: Fernando
  fullname: Fernando, Dharsh
– sequence: 15
  givenname: Mark
  surname: Horrigan
  fullname: Horrigan, Mark
– sequence: 16
  givenname: Anthony
  surname: Jackson
  fullname: Jackson, Anthony
– sequence: 17
  givenname: Leslie
  surname: Oliver
  fullname: Oliver, Leslie
– sequence: 18
  givenname: Nilesh
  surname: Mehta
  fullname: Mehta, Nilesh
– sequence: 19
  givenname: Voltaire
  surname: Nadurata
  fullname: Nadurata, Voltaire
– sequence: 20
  givenname: Nim
  surname: Nadarajah
  fullname: Nadarajah, Nim
– sequence: 21
  givenname: George
  surname: Proimos
  fullname: Proimos, George
– sequence: 22
  givenname: Michael
  surname: Rowe
  fullname: Rowe, Michael
– sequence: 23
  givenname: Ben
  surname: Sia
  fullname: Sia, Ben
– sequence: 24
  givenname: Christopher
  surname: Webb
  fullname: Webb, Christopher
– sequence: 25
  givenname: Nagesh
  surname: Anaveker
  fullname: Anaveker, Nagesh
– sequence: 26
  givenname: Peter
  surname: Barlis
  fullname: Barlis, Peter
– sequence: 27
  givenname: Paul
  surname: Calafiore
  fullname: Calafiore, Paul
– sequence: 28
  givenname: Boniface
  surname: Chan
  fullname: Chan, Boniface
– sequence: 29
  givenname: John
  surname: Cotroneo
  fullname: Cotroneo, John
– sequence: 30
  givenname: Jennifer
  surname: Johns
  fullname: Johns, Jennifer
– sequence: 31
  givenname: Elizabeth
  surname: Jones
  fullname: Jones, Elizabeth
– sequence: 32
  givenname: Paul
  surname: Kertes
  fullname: Kertes, Paul
– sequence: 33
  givenname: David
  surname: O'Donnell
  fullname: O'Donnell, David
– sequence: 34
  givenname: Stephen
  surname: Sylviris
  fullname: Sylviris, Stephen
– sequence: 35
  givenname: Anew
  surname: Tonkin
  fullname: Tonkin, Anew
– sequence: 36
  givenname: Robert
  surname: Fabini
  fullname: Fabini, Robert
– sequence: 37
  givenname: Leighton
  surname: Kearney
  fullname: Kearney, Leighton
– sequence: 38
  givenname: Ruth
  surname: Lim
  fullname: Lim, Ruth
– sequence: 39
  givenname: Maurice
  surname: Molan
  fullname: Molan, Maurice
– sequence: 40
  givenname: Gerard
  surname: Smith
  fullname: Smith, Gerard
– sequence: 41
  givenname: Chris
  surname: Wellman
  fullname: Wellman, Chris
– sequence: 42
  givenname: John
  surname: Eng
  fullname: Eng, John
– sequence: 43
  givenname: Irbaz
  surname: Hameed
  fullname: Hameed, Irbaz
– sequence: 44
  givenname: Margaret
  surname: Shaw
  fullname: Shaw, Margaret
– sequence: 45
  givenname: Sana
  surname: Gerbo
  fullname: Gerbo, Sana
Copyright 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc.
Copyright_xml – notice: 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc.
CorporateAuthor RAPCO Investigators
CorporateAuthor_xml – name: RAPCO Investigators
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1161/CIRCULATIONAHA.119.045427
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage 1338
ExternalDocumentID 10_1161_CIRCULATIONAHA_119_045427
33017209
00003017-202010060-00005
Genre Comparative Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID -
.XZ
.Z2
01R
0R
1AW
1J1
29B
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O
7O~
8RP
AAAXR
AAMOA
AAMTA
AAPBV
AARTV
AAWTL
AAXQO
ABBUW
ABFLS
ABOCM
ABPMR
ABPTK
ABUFD
ABXVJ
ABZAD
ACDDN
ACEWG
ACGFS
ACRKK
ACWDW
ACWRI
ACXNZ
ADBBV
ADCYY
AENEX
AFCHL
AFUWQ
AHMBA
AHULI
AHVBC
AIJEX
AJIOK
ALMA_UNASSIGNED_HOLDINGS
AMJPA
ASCII
ASPBG
AVWKF
AWKKM
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DU5
E3Z
EBS
EX3
F2K
F2L
F2M
F2N
F5P
H0
H0~
H1
HZ
IKYAY
IN
IN~
JF9
JG8
JK3
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O0-
O9-
OAG
OAH
OBH
OCB
ODA
OGEVE
OHASI
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWW
OWY
OXXIT
P2P
PQEST
PQQKQ
RAH
RHF
RIG
RLZ
S4R
S4S
UPT
V2I
W2D
WH7
WOQ
WOW
X3V
X3W
XZ
YZZ
Z2
ZA5
ZY1
~H1
---
.-D
.3C
0R~
0ZK
18M
2FS
2WC
354
6PF
AAAAV
AAGIX
AAHPQ
AAIQE
AAJCS
AAQKA
AASCR
AASOK
AASXQ
AAUEB
ABASU
ABDIG
ABJNI
ABQRW
ABVCZ
ACGFO
ACILI
ACLDA
ACOAL
ACXJB
ADGGA
ADHPY
AE3
AE6
AEBDS
AFDTB
AFEXH
AFSOK
AGINI
AHOMT
AHQNM
AHRYX
AINUH
AJNWD
AJZMW
AKULP
ALMTX
AMKUR
AMNEI
AOHHW
AYCSE
CGR
CUY
CVF
DIWNM
ECM
EEVPB
EIF
ERAAH
FCALG
GNXGY
GQDEL
GX1
HLJTE
HZ~
IKREB
IPNFZ
K-A
K-F
NPM
ODMTH
OHH
OHYEH
OJAPA
OLB
OWBYB
OWU
OWV
OWX
OWZ
T8P
TEORI
TR2
TSPGW
VVN
W3M
W8F
XXN
XYM
YFH
YOC
YSK
YYM
ZFV
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c4795-250c76b0e4cbe36a4faa3ac97976ad52c4b9c001baca161058560420b79beec83
ISSN 0009-7322
IngestDate Fri Aug 16 23:00:44 EDT 2024
Fri Aug 23 00:52:46 EDT 2024
Wed Oct 16 00:42:44 EDT 2024
Tue Oct 06 02:58:37 EDT 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 14
Keywords coronary artery bypass
saphenous vein
radial artery
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4795-250c76b0e4cbe36a4faa3ac97976ad52c4b9c001baca161058560420b79beec83
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ORCID 0000-0002-7074-7949
0000-0003-4680-0815
0000-0001-9554-6556
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.119.045427
PMID 33017209
PQID 2448847102
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2448847102
crossref_primary_10_1161_CIRCULATIONAHA_119_045427
pubmed_primary_33017209
wolterskluwer_health_00003017-202010060-00005
ProviderPackageCode OVOZU
L-C
C45
7O~
AARTV
ABPMR
OLH
ASCII
BYPQX
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
KMI
OGEVE
K8S
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
71W
AHULI
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OBH
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
~H1
AAMTA
AAAXR
OWW
OCB
OWY
01R
ACXNZ
OL1
AFCHL
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
PublicationCentury 2000
PublicationDate 2020-October-06
PublicationDateYYYYMMDD 2020-10-06
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-October-06
  day: 06
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2020
Publisher by the American College of Cardiology Foundation and the American Heart Association, Inc
Publisher_xml – name: by the American College of Cardiology Foundation and the American Heart Association, Inc
References 33017206 - Circulation. 2020 Oct 6;142(14):1339-1341
33872076 - Circulation. 2021 Apr 20;143(16):e832-e833
33872081 - Circulation. 2021 Apr 20;143(16):e834-e835
e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_11_2
e_1_3_4_22_2
e_1_3_4_12_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_10_2
e_1_3_4_21_2
e_1_3_4_15_2
e_1_3_4_16_2
e_1_3_4_13_2
e_1_3_4_24_2
e_1_3_4_14_2
e_1_3_4_19_2
e_1_3_4_17_2
e_1_3_4_18_2
References_xml – ident: e_1_3_4_9_2
  doi: 10.1016/j.hlc.2011.01.001
– ident: e_1_3_4_6_2
  doi: 10.1056/NEJMoa1716026
– ident: e_1_3_4_7_2
  doi: 10.1016/j.jtcvs.2008.10.029
– ident: e_1_3_4_15_2
  doi: 10.1016/j.jtcvs.2016.05.022
– ident: e_1_3_4_2_2
  doi: 10.1016/S0140-6736(19)31997-X
– ident: e_1_3_4_18_2
  doi: 10.1016/j.athoracsur.2012.12.038
– ident: e_1_3_4_3_2
  doi: 10.1161/CIR.0000000000000095
– ident: e_1_3_4_10_2
  doi: 10.1080/01621459.1999.10474144
– ident: e_1_3_4_20_2
  doi: 10.1001/jamasurg.2013.3721
– ident: e_1_3_4_21_2
  doi: 10.1093/icvts/ivz129
– ident: e_1_3_4_14_2
  doi: 10.1093/ejcts/ezv467
– ident: e_1_3_4_17_2
  doi: 10.1016/j.athoracsur.2017.10.058
– ident: e_1_3_4_19_2
  doi: 10.1016/j.jtcvs.2012.01.052
– ident: e_1_3_4_16_2
  doi: 10.1016/S0022-5223(19)36947-8
– ident: e_1_3_4_13_2
  doi: 10.1093/ejcts/ezv093
– ident: e_1_3_4_22_2
  doi: 10.1016/j.jtcvs.2011.10.029
– ident: e_1_3_4_4_2
  doi: 10.1161/JAHA.117.008010
– ident: e_1_3_4_24_2
  doi: 10.1016/s0003-4975(03)01018-x
– ident: e_1_3_4_8_2
  doi: 10.1161/CIRCULATIONAHA.104.512905
– ident: e_1_3_4_11_2
  doi: 10.1093/ejcts/ezu111
– ident: e_1_3_4_12_2
  doi: 10.1161/CIRCULATIONAHA.111.030536
– ident: e_1_3_4_5_2
  doi: 10.1056/NEJMoa1808783
– ident: e_1_3_4_23_2
  doi: 10.1053/j.semtcvs.2017.05.018
SSID ssj0006375
Score 2.6438217
Snippet BACKGROUND:An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best...
An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best second...
Background: An internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best...
BACKGROUNDAn internal thoracic artery graft to the left anterior descending artery is standard in coronary bypass surgery, but controversy exists on the best...
SourceID proquest
crossref
pubmed
wolterskluwer
SourceType Aggregation Database
Index Database
Publisher
StartPage 1330
SubjectTerms Adult
Aged
Coronary Artery Bypass
Disease-Free Survival
Female
Humans
Male
Mammary Arteries
Middle Aged
Mortality
Radial Artery
Survival Rate
Vascular Patency
Title Long-Term Results of the RAPCO Trials
URI http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-202010060-00005
https://www.ncbi.nlm.nih.gov/pubmed/33017209
https://search.proquest.com/docview/2448847102
Volume 142
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwED_BkKohhGDjUV7KJOALysjDceqPXWDqxgaotNK-RbbrwgRLpi7VGH8950ceFZ0EfIkiR3KSu9PPvzvfnQFeIgNm8ZxSP1SU-CSJpS_SWeqHYiajWchjFura4eOPdDQlhyfJSX3EvasuqcSu_LW2ruR_tIpjqFddJfsPmm0mxQG8R_3iFTWM17_S8VFZfPUniK06Cr_8YdMyNJMcDz9nn95MzCd06Wd2upDuvK51x_B0wgJ7y58usX5voTFgv4Wqq0tu8-FtMKaNho65C6ce8tNGkWVlge0LGkXhYrIuyoAupd4jdz2qHTJGRpdsBTpJ1LUR0kFC9H2D9RBNNUTL9n_5N46jbFc3A7R9AjqqOz8zusPJkGkFrF21mlzC-tFNuBWlLNFpne8OPjSrMY3TpAc77s1vr33vJvTqmVYpyh9-x224c1nqVIaL76aSocNHJvfgrnMkvKG1ivtwQxVbsD0seFWeXXmvPZPaa_ZMtqB37DIotuFVYzOesxmvnHtoM56xGc_azAOY7r-fZCPfHZXhS4I_7SORlSkVgSJSqJhyMuc85pKlyDb5LIkkEUwiIxFcchRDgE4iRbgORMqEUnIQP4SNoizUY_AUroEEWe6AGX8aXd40YVzNI0WUElL0Iaqlk5_bjii58SRpmGcH42x6ZNs4j4Y4xnIr3T7s1HLMEb_0phQvVLm8yJFeDjRDCqI-PLICbqatFdIHf0Xiua0R1okT2qNPfW2xoW4tpJskBMmTa2d6CputdT-DjWqxVM-RVVbihTGb38YbbNk
link.rule.ids 315,786,790,27955,27956
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-Term+Results+of+the+RAPCO+Trials&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Buxton%2C+Brian+F&rft.au=Hayward%2C+Philip+A&rft.au=Raman%2C+Jai&rft.au=Moten%2C+Simon+C&rft.date=2020-10-06&rft.eissn=1524-4539&rft.volume=142&rft.issue=14&rft.spage=1330&rft_id=info:doi/10.1161%2Fcirculationaha.119.045427&rft_id=info%3Apmid%2F33017209&rft.externalDocID=33017209
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon